Extracorporeal life support for severe respiratory failure in children with immune compromised conditions*
- 1 July 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pediatric Critical Care Medicine
- Vol. 9 (4), 380-385
- https://doi.org/10.1097/pcc.0b013e318172d54d
Abstract
Objectives: To examine a large cohort of children treated with extracorporeal life support (ECLS) for severe respiratory failure to investigate the hypothesis that patients with an immune compromise condition (ICC) would have reduced survival to hospital discharge compared with patients without this classification. Design: Retrospective cohort study. Setting: Extracorporeal Life Support Organization (ELSO) data registry. Patients: All nonneonatal pediatric patients receiving ECLS for respiratory failure. Interventions: None. Measurements and Main Results: As of February 4, 2004, the ELSO registry contained 2,879 pediatric patients between 1 month and 19 yrs of age who were treated with ECLS for respiratory failure. Overall, 183 patients had at least one International Classification of Diseases (Ninth Revision) or Current Procedural Terminology code associated with an ICC; ICC status was associated with lower hospital survival (31 vs. 57 %; p < .001). Six ICC subgroups were also examined: immune deficiency, leukemia-lymphoma, cancer, opportunistic infection, solid organ transplant, and bone marrow transplant. Each ICC subgroup was also associated with reduced hospital survival, varying from a high of 34.6% (solid organ transplants) to a low of 0% (bone marrow transplant). In a multivariate logistic regression model that controlled for factors reported to be associated with survival and other respiratory interventions (high-frequency ventilation, inhaled nitric oxide, and surfactant), the presence of an ICC remained associated with reduced hospital survival (odds ratio 0.20–0.45; p < .001). In this multivariate model, an unexpected strong association between inhaled nitric oxide therapy and lower ECLS survival was observed (odds ratio 0.49–0.80; p < .001). Conclusions: In this cohort of pediatric patients receiving ECLS for respiratory failure, survival to hospital discharge was reduced for each ICC subgroup examined and was approximately one in three for the overall group. Further study of the association of lower survival rates for patients who received inhaled nitric oxide prior to ECLS is needed.Keywords
This publication has 31 references indexed in Scilit:
- CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failureBMC Health Services Research, 2006
- Oxygenation Index Predicts Outcome in Children with Acute Hypoxemic Respiratory FailureAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Effect of Exogenous Surfactant (Calfactant) in Pediatric Acute Lung InjuryA Randomized Controlled TrialJAMA, 2005
- UK collaborative randomised trial of neonatal extracorporeal membrane oxygenationThe Lancet, 1996
- The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failureCritical Care Medicine, 1996
- Acute hypoxemic respiratory failure in children following bone marrow transplantationCritical Care Medicine, 1995
- Predictors of acute respiratory failure after bone marrow transplantation in childrenCritical Care Medicine, 1994
- Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.American Journal of Respiratory and Critical Care Medicine, 1994
- Acute hypoxemic respiratory failure in infants and childrenCritical Care Medicine, 1992
- Extracorporeal Membrane Oxygenation in Severe Acute Respiratory FailureJAMA, 1979